Molecular probes for the in vivo imaging of cancer
Molecular BioSystems2009Vol. 5(11), pp. 1279–1291
Citations Over TimeTop 10% of 2009 papers
Abstract
Advancements in medical imaging have brought about unprecedented changes in the in vivo assessment of cancer. Positron emission tomography, single photon emission computed tomography, optical imaging, and magnetic resonance imaging are the primary tools being developed for oncologic imaging. These techniques may still be in their infancy, as recently developed chemical molecular probes for each modality have improved in vivo characterization of physiologic and molecular characteristics. Herein, we discuss advances in these imaging techniques, and focus on the major design strategies with which molecular probes are being developed.
Related Papers
- → Bioresponsive probes for molecular imaging: concepts and in vivo applications(2015)31 cited
- → <i>In Vivo</i> Molecular Imaging(2017)30 cited
- → In Vivo Molecular Imaging for Biomedical Analysis and Therapies(2018)16 cited
- → New in vivo optical molecular imaging modalities(2011)
- → In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead(2014)